Literature DB >> 16914706

Tumor necrosis factor inhibitors for rheumatoid arthritis.

D L Scott1, G H Kingsley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914706     DOI: 10.1056/NEJMct055183

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  118 in total

1.  Hepatitis C virus treatment complicated by rheumatoid arthritis.

Authors:  Meredith Borman; Mark G Swain
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 2.  Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.

Authors:  Jeffrey T Gu; Linda Nguyen; Abhijit J Chaudhari; John D MacKenzie
Journal:  Top Magn Reson Imaging       Date:  2011-04

3.  Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Authors:  Guang Yang; Min Wan; Yongsheng Zhang; Luguo Sun; Ran Sun; Dali Hu; Xiaojing Zhou; Li Wang; Xiuli Wu; Liying Wang; Yongli Yu
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

4.  ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment.

Authors:  Stefania Girlanda; Paola Mantegani; Elena Baldissera; Patrizia Aiello; Manuela Ratti; Maria Grazia Sabbadini; Claudio Fortis
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

5.  Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis. A prospective study on efficacy and safety in a Saudi population.

Authors:  R H A Mohammed; H H Kewan; M Bukhari
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

Review 6.  [Anti-TNF-α treatment for uveitis. Analysis of the current situation].

Authors:  U Pleyer; F Mackensen; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

7.  Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.

Authors:  Wenhui Hu; Hantamalala Ralay Ranaivo; Saktimayee M Roy; Heather A Behanna; Laura K Wing; Lenka Munoz; Ling Guo; Linda J Van Eldik; D Martin Watterson
Journal:  Bioorg Med Chem Lett       Date:  2006-10-17       Impact factor: 2.823

Review 8.  In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy.

Authors:  Alastair J M Watson
Journal:  Gut       Date:  2007-04       Impact factor: 23.059

9.  Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.

Authors:  Sophia Li; Primal P Kaur; Virginia Chan; Steven Berney
Journal:  Clin Rheumatol       Date:  2009-03-17       Impact factor: 2.980

10.  NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesis.

Authors:  Sakae Tanaka; Hiroyasu Nakano
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.